Edition:
United States

Cosmo Pharmaceuticals NV (COPN.S)

COPN.S on Swiss Exchange

135.80CHF
11:30am EDT
Change (% chg)

CHF-0.90 (-0.66%)
Prev Close
CHF136.70
Open
CHF137.00
Day's High
CHF137.40
Day's Low
CHF133.60
Volume
8,776
Avg. Vol
22,062
52-wk High
CHF155.00
52-wk Low
CHF103.60

Chart for

About

COSMO Pharmaceuticals SA is a Luxembourg-based pharmaceutical company engaged in the development and production of drugs against selected gastrointestinal diseases. Its clinical research aims to treat Inflammatory Bowel Diseases (IBD), such as ulcerative colitis and Crohn’s disease, as well as colon infections and skin... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): €1,800.26
Shares Outstanding(Mil.): 15.04
Dividend: --
Yield (%): --

Financials

  COPN.S Industry Sector
P/E (TTM): -- 28.11 30.17
EPS (TTM): 0.24 -- --
ROI: 5.61 12.95 12.67
ROE: 6.12 14.96 14.86

BRIEF-Cosmo Pharmaceuticals H1 Revenue Up 15.2 Pct To EUR 36.7 Million

* H1 REVENUE UP 15.2% TO EUR36.7M DRIVEN BY UP-FRONT LICENSE FEESÂ

Jul 26 2018

Earnings vs. Estimates

No consensus analysis data available.